Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hughes-Wilson Alexandra Insider Profile
4 Followers
Hughes-Wilson Alexandra, Chief Patient Access and Commercial Planning at Mereo Biopharma Group Plc, holds 50.48K shares in Mereo Biopharma Group Plc (Ticker: MREO).
Hughes-Wilson Alexandra Mereo Biopharma Group Plc (MREO)Chief Patient Access and Commercial Planning
Mereo Biopharma Group Plc (MREO)
Chief Patient Access and Commercial Planning
Not Ranked
Hughes-Wilson Alexandra has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Hughes-Wilson Alexandra's holdings
Insider Roles
Chief Patient Access and Commercial Planning
Roles that Hughes-Wilson Alexandra holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Sep 16, 2024 - Today
Return:+17.30%
The most profitable trade made by Hughes-Wilson Alexandra
Hughes-Wilson Alexandra's Trading History
List of latest transactions for each holding click on a transaction to see Hughes-Wilson Alexandra's performance on stock
You May Also Like
Hughes-Wilson Alexandra insider profile FAQ
What is the percentage of profitable transactions made by Hughes-Wilson Alexandra?
The percentage of profitable transactions made by Hughes-Wilson Alexandra is ―.
What is the average return per transaction made by Hughes-Wilson Alexandra?
The average return per transaction made by Hughes-Wilson Alexandra is ―.
What stocks does Hughes-Wilson Alexandra hold?
Hughes-Wilson Alexandra holds: MREO stocks.
What was Hughes-Wilson Alexandra’s latest transaction?
Hughes-Wilson Alexandra latest transaction was an Uninformative Sell of $103.53K.
What was Hughes-Wilson Alexandra's most profitable transaction?
Hughes-Wilson Alexandra’s most profitable transaction was an Informative Sell of MREO stock on September 16, 2024. The return on the trade was 17.30%.
What is Hughes-Wilson Alexandra's role in Mereo Biopharma Group Plc?
Hughes-Wilson Alexandra's role in Mereo Biopharma Group Plc is Chief Patient Access and Commercial Planning.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.